Carafate 1 GM Oral Tablet
RxNorm 208097
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 208097 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Carafate 1 GM Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Carafate 1 GM Oral Tablet
(Atom ID: 6363713)
SYPrescribable
Synonym (SY):
Carafate 1000 mg Oral Tablet
(Atom ID: 1157937)
SBDPrescribable
Semantic Branded Drug (SBD):
Sucralfate 1000 mg Oral Tablet [Carafate]
(Atom ID: 12356188)
Patient Education
Sucralfate
Sucralfate is used to treat and prevent the return of duodenal ulcers (ulcers located in first part of the small intestine). Treatment with other medications, such as antibiotics, may also be necessary to treat and prevent the return of ulcers caused by a certain type of bacteria (H. pylori) Sucralfate is in a class of medications called protectants. It sticks to damaged ulcer tissue and protects against acid and enzymes so healing can occur.
[Learn More]
* Please review the disclaimer below.